Validation pour Ingenuity080

vers la météo de la validation par utilisateur

Ingenuity080

precedent - 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 - suivant

Phrase 79 - PMID ?

Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of SP NODE mRNA in Hela cells treated with agonist anti SP Apo 1 [NODE] protein antibody and overproducing SP NODE protein .

Non annotée
Je ne sais pas
Je n'ai pas trouvé d'analyse satisfaisante

Commentaires :

Analyse 0

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      +---COMP:V_PASS-N(with)---+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 1

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                          |              |                                +--------------COMP:N-N(in)-------------+      +---COMP:V_PASS-N(with)---+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 2

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                              +------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 3

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                                                        +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 4

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+------COMP:V_PASS-N(with)-----+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 5

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 6

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 7

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 8

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 9

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                         +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 10

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                                       |                                +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 11

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------COMP:N-N(in)-------------+      +---COMP:V_PASS-N(with)---+                                                          |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 12

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 13

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |                                |                                       |      +---COMP:V_PASS-N(with)---+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 14

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                         +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 15

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 16

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 17

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 18

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+--------COMP:V-N(with)--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 19

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 20

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 21

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              |                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 22

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           +------COMP:V-N(with)-----+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 23

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +------------COMP:N-N(with)-----------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 24

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 25

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 26

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |                                |                          |                   +---COMP:V_PASS-N(with)---+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 27

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 28

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 29

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                         +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 30

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 31

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                                                        +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 32

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 33

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 34

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                +--------------------------COMP:V-N(with)--------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 35

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 36

                                                                                                                         +-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         +----------------------------------COMP:V-N(in)---------------------------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |                                +-----------------COMP:V-N(in)-----------------+------COMP:V-N(with)-----+                                |                                         |     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 37

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +----------------------------------------------SUBJ:V-N---------------------------------------------+             
                          |              |                                |                                       |             +-----------------------------------OBJ:V-N-----------------------------------+       |             
                          |              |                                |                                       |             +----------------------OBJ:V-N----------------------+                         |       |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                           |                         |       |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                         |       |             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 38

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 39

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 40

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                |           +--------------OBJ:V-N-------------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 41

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 42

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                             +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 43

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 44

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 45

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 46

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 47

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 48

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 49

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 50

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+------COMP:V_PASS-N(with)-----+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 51

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 52

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                   +------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                          |                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 53

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 54

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |                   +---COMP:V_PASS-N(with)---+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 55

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                         +--------------------------COMP:V-N(with)--------------------------+             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 56

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                          |            |                                +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 57

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+------------------COMP:N-N(with)------------------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 58

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 59

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+      +---COMP:V_PASS-N(with)---+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 60

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 61

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 62

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +------------------COMP:N-N(with)------------------+                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 63

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 64

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                   +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 65

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           +--------COMP:V-N(with)--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 66

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                              |                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 67

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 68

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 69

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 70

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                                                                 +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 71

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------COMP:N-N(in)-------------+                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          |                                      +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 72

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 73

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                |                   +----------OBJ:V-N---------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 74

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                   +------COMP:V_PASS-N(with)-----+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 75

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 76

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                             +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 77

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 78

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 79

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 80

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 81

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 82

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 83

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 84

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |                                |                          |                   +------COMP:V-N(with)-----+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+                          |                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 85

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              +--------------------COMP:V-N(with)-------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 86

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |            +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 87

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |             +---------------------------COMP:V-N(in)--------------------------+                                                                                                          
                                         |             |                  +-------------------SUBJ:V-N-------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |             |                  +--------------COMP:N-N(in)-------------+      +--------------------------OBJ:V-N-------------------------+                                         |     
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 88

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 89

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 90

                                         +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 91

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                                              +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 92

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 93

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------COMP:N-N(in)-------------+                                     |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                                     |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 94

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 95

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +------------------COMP:N-N(with)------------------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 96

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                                       |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 97

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 98

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 99

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +----------------------------------------------SUBJ:V-N---------------------------------------------+             
                                         |                                |                                       |             +-----------------------------------OBJ:V-N-----------------------------------+       |             
                                         |                                |                                       |             +----------------------OBJ:V-N----------------------+                         |       |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                           |                         |       |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                         |       |             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 100

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +----------------------------------------------SUBJ:V-N---------------------------------------------+             
                                         |                                |                                       |             +-----------------------------------OBJ:V-N-----------------------------------+       |             
                                         |                                |                                       |             +----------------------OBJ:V-N----------------------+                         |       |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                           |                         |       |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+                         |       |             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,__SP__)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,cell)
OBJ:V-N (__NODE__,protein)

Analyse 101

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                                                    |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 102

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 103

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 104

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                                                                                    |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 105

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 106

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                   |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 107

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 108

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 109

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 110

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 111

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 112

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 113

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                                       +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 114

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 115

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                          +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 116

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 117

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                                                          +-------------SUBJ:V-N------------+             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 118

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 119

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 120

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 121

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                   |                                      +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 122

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 123

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +------------------COMP:N-N(with)------------------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 124

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 125

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                                                  +------------------------COMP:V-N(with)-----------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 126

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                         +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 127

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                             +--------------------------COMP:V-N(with)--------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 128

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                          |            |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 129

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 130

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 131

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                                                                                            |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 132

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 133

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 134

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                       +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                          |              |                                |                                       |      +---COMP:V_PASS-N(with)---+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 135

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                          +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 136

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 137

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 138

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 139

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                         +--------------------------COMP:V-N(with)--------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 140

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 141

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 142

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 143

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 144

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 145

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                          |              |                                +-----------------COMP:V-N(in)-----------------+                                                                                                          
                          |              |                                +-----------COMP:N-N(in)-----------+           +-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           +--------------------------OBJ:V-N-------------------------+              +-------MOD_ATT:N-ADJ------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 146

                                                                                                                                                   +----------------------------------OBJ:V-N---------------------------------+     
                                                                                                                                                   |       +----------------------------MOD_ATT:N-N---------------------------+     
                          +------------------------------------------------------COMP:V-N(in)------------------------------------------------------+       |      +------------------------MOD_ATT:N-N------------------------+     
                          |              +-----------------------------------------------COMP:V-N(in)----------------------------------------------+       |      |        +--------------------MOD_ATT:N-N-------------------+     
                          |              |                                +------------------------------COMP:V-N(in)------------------------------+       |      |        |        +---------------MOD_ATT:N-N---------------+     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +----------COMP:V-N(in)----------+       |      |        |        |              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +COMP:V-N(wit+       |      |        |        |              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +SUBJ:+       |      |        |        |              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |       |      |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (protein,protein)
MOD_ATT:N-N (protein,antibody)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 147

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |                                +-----------------COMP:V-N(in)-----------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------COMP:N-N(in)-----------+           +--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 148

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                                                                                |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 149

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                                                                                           |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 150

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 151

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 152

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 153

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 154

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      +--------COMP:V-N(with)--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 155

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 156

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 157

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 158

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 159

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |                                |                          |            |      +---COMP:V_PASS-N(with)---+                                                                  |             
                                         |       +-------MOD_ATT:N-N------+                          |            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 160

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +------COMP:V_PASS-N(with)-----+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 161

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+------COMP:V_PASS-N(with)-----+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 162

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                          +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 163

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 164

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 165

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 166

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +------------------COMP:N-N(with)------------------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 167

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 168

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                                                           +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 169

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 170

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +--------------------------COMP:N-N(with)-------------------------+                                                             |             
                          |              |                                |           +--------------OBJ:V-N-------------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (__SP__,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 171

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 172

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                              |                           +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 173

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                          |              |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 174

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 175

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 176

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                                  |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 177

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+            |      |                              +------------------------COMP:V-N(with)-----------------------+             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 178

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 179

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+------COMP:V-N(with)-----+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 180

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +------------COMP:N-N(with)-----------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 181

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                          |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 182

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 183

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 184

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 185

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 186

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 187

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 188

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +--------------COMP:N-N(in)-------------+      +------COMP:V-N(with)-----+                                                          |                     
                          |              |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 189

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 190

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                          |              |                                +--------------COMP:N-N(in)-------------+      |                         +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 191

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |                                                  +------------------------COMP:V-N(with)-----------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                              |                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 192

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 193

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 194

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 195

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                                                                                    |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 196

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          +------------------COMP:N-N(with)------------------+                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 197

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              +----------------------------------COMP:V-N(in)---------------------------------+--------------------------OBJ:V-N-------------------------+                                         |     
                          |              |                                +-----------------COMP:V-N(in)-----------------+------COMP:V-N(with)-----+                                |                                         |     
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 198

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |                                +-----------------COMP:V-N(in)-----------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                |                   +-------COMP:V-N(of)-------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 199

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                                                                                            |             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 200

                                                                                                                                                   +----------------------------------OBJ:V-N---------------------------------+     
                                                                                                                                                   |       +----------------------------MOD_ATT:N-N---------------------------+     
                                         +-----------------------------------------------COMP:V-N(in)----------------------------------------------+       |      +------------------------MOD_ATT:N-N------------------------+     
                                         |                                +------------------------------COMP:V-N(in)------------------------------+       |      |        +--------------------MOD_ATT:N-N-------------------+     
                                         |                                +--------------------OBJ:V-N-------------------+                         |       |      |        |        +---------------MOD_ATT:N-N---------------+     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                         |       |      |        |        |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |                         |       |      |        |        |              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +MOD:V-+     +MOD_AT+SUBJ:+       |      |        |        |              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |       |      |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
MOD:V-ADV (treat,with)
MOD_ATT:N-N (anti,agonist)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (protein,protein)
MOD_ATT:N-N (protein,antibody)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 201

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 202

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 203

                                         +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                          +----COMP:V-N(of)---+      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,mRNA)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 204

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 205

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 206

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 207

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                          |              |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 208

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 209

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                                                            |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 210

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+--------COMP:V-N(with)--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 211

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 212

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                                       |                                      +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 213

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |                                +-----------COMP:N-N(in)-----------+           |            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 214

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 215

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 216

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +------------------COMP:N-N(with)------------------+                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 217

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 218

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |                                                                                    |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 219

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                                                        +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 220

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 221

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                                                        +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 222

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 223

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 224

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 225

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 226

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 227

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 228

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |                                             +--------------------------COMP:V-N(with)--------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 229

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +------COMP:V_PASS-N(with)-----+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 230

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 231

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      +------COMP:V_PASS-N(with)-----+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 232

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                                         |             |                  +--------------COMP:N-N(in)-------------+      +------COMP:V-N(with)-----+                                                          |                     
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 233

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 234

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |                                +--------------------OBJ:V-N-------------------+                              |                                                     |                     
                                         |                                +-----------COMP:N-N(in)-----------+           |                              |                                                     |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 235

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 236

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 237

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 238

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 239

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |                                |                          |            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |                          |                                      +-------------SUBJ:V-N------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 240

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 241

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +------------------COMP:N-N(with)------------------+                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 242

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                                   |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 243

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 244

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+                              +--------------------COMP:V-N(with)-------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 245

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 246

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                           +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 247

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                       +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                          |              |                                |                                       |                   +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 248

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 249

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+                   |                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 250

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |             |                  +-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 251

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 252

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                                              +------COMP:V-N(with)-----+                                                          |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 253

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+            +-----------------------------COMP:V-N(with)----------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 254

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 255

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                         +----------------------COMP:V-N(with)----------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 256

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                           |              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 257

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                          |              |       +-------MOD_ATT:N-N------+                          +----COMP:V-N(of)---+      +--------OBJ:V-N--------+                           |              +-------MOD_ATT:N-ADJ------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,mRNA)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 258

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 259

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |             +---------------------------COMP:V-N(in)--------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |             |                  +-------------------SUBJ:V-N-------------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |             |                  +--------------COMP:N-N(in)-------------+      +------COMP:V-N(with)-----+                                |                                         |     
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 260

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                                                                                            |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 261

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 262

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 263

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 264

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                            |             
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 265

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                                       +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 266

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 267

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 268

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 269

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |                                                  +--------------------COMP:V-N(with)-------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 270

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                                  +------------------------------------------COMP:V-N(in)------------------------------------------+                     
                          |              |                                |                                  |    +------------------------------------------SUBJ:V-N-----------------------------------------+                     
                          |              |                                |                                  |    |             +------------------------------OBJ:V-N-----------------------------+          |                     
                          |              |                                |                                  |    |             +----------------------OBJ:V-N----------------------+              |          |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |    |      +------COMP:V_PASS-N(with)-----+                           |              |          |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |    |      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,overproduce)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,Hela)
SUBJ:V-N (__SP__,cell)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 271

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                                                                                           |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+COMP:V_PASS-+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 272

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |                          +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 273

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 274

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 275

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |             +-------------------------------------------------------------------------COMP:V-N(in)-------------------------------------------------------------------------+             
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                            |             
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                            |             
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                            |             
                                         |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,culture)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 276

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 277

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                              +--------------------COMP:V-N(with)-------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 278

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                          +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 279

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +--------------COMP:N-N(in)-------------+      |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |             |                  +-------COMP:N-N(of)-------+            |      |      +--------OBJ:V-N--------+                                                     |                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+            |      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 280

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+--------COMP:V-N(with)--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 281

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |                                |                          |                                             +----------------------COMP:V-N(with)----------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 282

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 283

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 284

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   |                                      +-------------SUBJ:V-N------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              +-----SUBJ:V-N-----+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +--OBJ:V-N-+       +OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
OBJ:V-N (overproduce,__SP__)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,overproduce)
OBJ:V-N (__NODE__,protein)

Analyse 285

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 286

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 287

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------COMP:N-N(in)-------------+                                                                                           |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +------------COMP:N-N(with)-----------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 288

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 289

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                         +----------------------COMP:V-N(with)----------------------+                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 290

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                                         |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                                         |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                                         |             |                  +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |             |                  +-------COMP:N-N(of)-------+            |      +--------COMP:V-N(with)--------+                                                     |                     
                          +--MOD_ATT:N-N-+             |                  |           +-MOD_ATT:N-ADJ+            |      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 291

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                          |              |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              |                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 292

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                            |             
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 293

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 294

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                             |             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 295

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 296

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 297

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+---SUBJ:V_PASS-N---+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 298

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 299

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 300

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 301

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                   +--------COMP:V-N(with)--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 302

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-ADJ (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 303

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            +------------COMP:N-N(with)-----------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 304

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 305

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 306

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 307

                                         +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 308

                                                                                                                                                   +----------------------------------OBJ:V-N---------------------------------+     
                                                                                                                                                   |       +----------------------------MOD_ATT:N-N---------------------------+     
                                                                                                                                                   |       |      +------------------------MOD_ATT:N-N------------------------+     
                                         +-----------------------------------------------COMP:V-N(in)----------------------------------------------+       |      |        +--------------------MOD_ATT:N-N-------------------+     
                                         |                                +------------------------------COMP:V-N(in)------------------------------+       |      |        |        +---------------MOD_ATT:N-N---------------+     
                                         |       +-------MOD_ATT:N-N------+                          +-----------------COMP:V-N(of)----------------+       |      |        |        |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+                         |       |      |        |        |              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +SUBJ:+       |      |        |        |              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |       |      |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,anti)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-N (protein,1)
MOD_ATT:N-N (protein,[__NODE__])
MOD_ATT:N-N (protein,protein)
MOD_ATT:N-N (protein,antibody)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 309

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |            |                   +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 310

                                         +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 311

                                         +----------------------------------COMP:V-N(in)---------------------------------+      +-------------------------------------------OBJ:V-N-------------------------------------------+     
                                         |                                +-----------------COMP:V-N(in)-----------------+      +----------------------OBJ:V-N----------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------COMP:V-N(with)--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 312

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 313

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              +------------------------COMP:V-N(with)-----------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
COMP:V-N(with) (__NODE__,Apo)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 314

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            |                          +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 315

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 316

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                       +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 317

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +--------------------------COMP:N-N(with)-------------------------+                                                             |             
                                         |                                |           +--------------OBJ:V-N-------------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (__SP__,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 318

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 319

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 320

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                             |             
                                         |                                +--------------------OBJ:V-N-------------------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 321

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+            +---------------------------------COMP:V-N(with)--------------------------------+             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 322

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 323

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 324

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              +--------------------COMP:V-N(with)-------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 325

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+------COMP:V_PASS-N(with)-----+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 326

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                              +--------------------COMP:V-N(with)-------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 327

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                                         |                                |                   +----------------------COMP:N-N(with)---------------------+                                                     |                     
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(with) (__NODE__,Apo)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 328

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                            |             
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                                                                                            |             
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 329

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 330

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   |                                                                                    |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 331

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 332

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                          |              |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      +COMP:V-N(wit+      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 333

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |                                |                          |            +--------------------------------------------COMP:V-N(in)-------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(in) (__NODE__,cell)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 334

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |                                |                          |            +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |            |                                     +--------------------COMP:V-N(with)-------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(in) (__SP__,cell)
COMP:V-N(with) (__SP__,Apo)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 335

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                                       +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |             +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(in) (__SP__,cell)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 336

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                                                           +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                          +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 337

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                                  |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 338

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          |                   +------COMP:V-N(with)-----+                                                          |                     
                                         |       +-------MOD_ATT:N-N------+                          |                   |      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 339

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+------COMP:V-N(with)-----+                                                          |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 340

                                                                                                                         +-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                                                                                                         +--------------------------OBJ:V-N-------------------------+                                         |     
                                         +----------------------------------COMP:V-N(in)---------------------------------+------COMP:V-N(with)-----+                                |                                         |     
                                         |       +-------MOD_ATT:N-N------+-----------------COMP:V-N(in)-----------------+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+----COMP:V-N(of)---+      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+    |         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,__SP__)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 341

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                                       +-----------------------------COMP:V-N(with)-----------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 342

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |                          +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 343

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 344

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 345

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 346

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 347

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          |            +------------COMP:N-N(with)-----------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+                   +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:N-N(with) (cell,Apo)
SUBJ:V_PASS-N (treat,cell)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 348

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +-----------------SUBJ:V_PASS-N----------------+                                                                                    |                     
                                         |                                +--------------COMP:N-N(in)-------------+      |                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+            |      |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,cell)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 349

                          +----------------------------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------------------------+             
                          |              +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                          |              |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                          |              |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                          |              |       +-------MOD_ATT:N-N------+                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,culture)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 350

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 351

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |             +---------------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------------+                     
                          |              |             +-----------------------------OBJ:V-N-----------------------------+                                                                                    |                     
                          |              |             |                  +-------------------SUBJ:V-N-------------------+                                                                                    |                     
                          |              |             |                  +-------COMP:N-N(of)-------+                   |                   +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |             |                  |           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       +MOD_A+        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,culture)
SUBJ:V-N (treat,expression)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 352

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 353

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                          |              |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 354

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                          |              |       +-------MOD_ATT:N-N------+                          |                                       +-------------------------COMP:V-N(with)-------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 355

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                +--------------------OBJ:V-N-------------------+                                                                                    |                     
                          |              |                                +-----------COMP:N-N(in)-----------+           |                                                                                    |                     
                          |              |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+       |           |            +-----------------------------COMP:V-N(with)----------------------------+                     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       |           |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
COMP:N-N(in) (expression,Hela)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 356

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+            +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 357

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+----COMP:N-N(of)---+      +COMP:N-N(in)+      +---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__NODE__)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 358

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          +------------------COMP:N-N(with)------------------+                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
COMP:N-N(with) (mRNA,Apo)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 359

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |                                +-----------------COMP:V-N(in)-----------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                   +--------------------------OBJ:V-N-------------------------+              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+                   |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 360

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |                                +-----------------COMP:V-N(in)-----------------+--------------------------OBJ:V-N-------------------------+                                         |     
                          |              |       +-------MOD_ATT:N-N------+                          +----COMP:V-N(of)---+      +--------OBJ:V-N--------+                           |              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+       +COMP:V-N(in+---COMP:V-N(with)--+          |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       |    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,mRNA)
COMP:V-N(in) (treat,Hela)
SUBJ:V-N (treat,cell)
COMP:V-N(with) (treat,anti)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-ADJ (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 361

                                         +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                                         |                                +-----------------COMP:V-N(in)-----------------+      +-------------------------------------------OBJ:V-N-------------------------------------------+     
                                         |                                |                   +-------COMP:V-N(of)-------+      +----------------------OBJ:V-N----------------------+                                         |     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+--------COMP:V-N(with)--------+                           |              +--------MOD_ATT:N-N-------+     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,Apo)
OBJ:V-N (with,antibody)
OBJ:V-N (with,protein)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 362

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                          +--------------------------------------------------COMP:V-N(of)--------------------------------------------------+             
                                         |       +-------MOD_ATT:N-N------+                          |                                +---------------------------------COMP:V-N(with)--------------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,mRNA)
COMP:V-N(with) (__NODE__,agonist)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 363

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |           +----------------------------------------------------------COMP:V-N(of)---------------------------------------------------------+             
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                            |             
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                   +-----------------------------COMP:V-N(with)-----------------------------+             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__SP__)
COMP:V-N(with) (__NODE__,anti)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 364

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                +--------------------------------COMP:N-N(with)-------------------------------+                                                     |                     
                                         |                                +--------------------OBJ:V-N-------------------+                              |                                                     |                     
                                         |       +-------MOD_ATT:N-N------+                          +------SUBJ:V-N-----+                              |                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                          +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+COMP:N-N(of+       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,__SP__)
COMP:N-N(with) (expression,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,expression)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 365

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------------------COMP:N-N(with)---------------------+                                                             |             
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(with) (__NODE__,Apo)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 366

                                         +--------------------------------------------------------------------------------COMP:V-N(in)--------------------------------------------------------------------------------+             
                                         |                                +----------------------------------------------------------------COMP:V-N(in)---------------------------------------------------------------+             
                                         |                                |                   +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+             
                                         |                                |                   +----------------------COMP:N-N(with)---------------------+                                                             |             
                                         |                                |                   +----------OBJ:V-N---------+                              |                                                             |             
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+                              |                                                             |             
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+-------------SUBJ:V-N------------+             
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +MOD_ATT:N-+SUBJ:V-+OBJ:V-N+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(with) (__NODE__,Apo)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (__SP__,overproduce)
COMP:V-N(in) (__NODE__,FMK)
COMP:V-N(in) (__NODE__,expression)
COMP:V-N(of) (__NODE__,__NODE__)
SUBJ:V-N (__NODE__,antibody)
SUBJ:V-N (__NODE__,__SP__)
OBJ:V-N (__NODE__,protein)

Analyse 367

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                +-----------------------------COMP:V-N(with)----------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 368

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+-------COMP:N-N(of)-------+                                       +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+------OBJ:V-N------+      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+COMP:N-+    +SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(of) (expression,mRNA)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,Hela)
OBJ:V-N (treat,mRNA)
SUBJ:V-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 369

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          |            +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          |            |             +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |      +COMP:V_PASS-N(with)+          |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
COMP:V_PASS-N(with) (treat,anti)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(in) (__SP__,cell)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 370

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 371

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                   +--------------------------------------------------COMP:V-N(of)-------------------------------------------------+                     
                                         |                                |                   +----------OBJ:V-N---------+            +-----------------------------COMP:V-N(with)----------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                   |      +------SUBJ:V-N-----+      +--------OBJ:V-N--------+                                                     |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+                   |      +COMP:N-N(in)+      |      |     +---OBJ:V-N--+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           +MOD_ATT+      |       +MOD_+      |      |     |      +SUBJ:+    |         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (__NODE__,__SP__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__NODE__)
SUBJ:V-N (treat,mRNA)
OBJ:V-N (with,Apo)
OBJ:V-N (__SP__,agonist)
SUBJ:V-N (__SP__,anti)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__NODE__)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 372

                          +-----------------------------------------COMP:V-N(in)-----------------------------------------+                                                                                                          
                          |              +----------------------------------COMP:V-N(in)---------------------------------+                                                                                                          
                          |              |                                +-----------------COMP:V-N(in)-----------------+                                                                                                          
                          |              |                                |           +-----------COMP:V-N(of)-----------+-----------------------------------------------OBJ:V-N----------------------------------------------+     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+--------------------------OBJ:V-N-------------------------+              +--------MOD_ATT:N-N-------+     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+              |          +-MOD_ATT:N-ADJ-+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              |          |       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
COMP:V-N(in) (treat,culture)
COMP:V-N(in) (treat,FMK)
COMP:V-N(in) (treat,expression)
COMP:V-N(of) (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (treat,antibody)
OBJ:V-N (treat,protein)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
MOD_ATT:N-N (protein,overproduce)
MOD_ATT:N-ADJ (protein,__SP__)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 373

                          +------------------------------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------------------------------+                     
                          |              +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                          |              |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                          |              |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                          |              |                                |           +--------------------------COMP:N-N(with)-------------------------+                                                     |                     
                          |              |                                |           +--------------OBJ:V-N-------------+                              |                                                     |                     
                          |              |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                              |                                                     |                     
                          |              |       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |            +-MOD_ATT:N-N+    |         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |            |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |            |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
COMP:N-N(with) (__SP__,Apo)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
MOD_ATT:N-N (__SP__,agonist)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,culture)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 374

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          +---SUBJ:V_PASS-N---+                   +-------------------------COMP:V-N(with)-------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      |      |     +MOD_AT+     +MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,mRNA)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (anti,agonist)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(with) (__SP__,anti)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 375

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |                          +----------------------------------------------COMP:V-N(of)----------------------------------------------+                     
                                         |                                |                          |            +----------------------------------------COMP:V-N(in)---------------------------------------+                     
                                         |       +-------MOD_ATT:N-N------+                          |            |                   +-----------------------------COMP:V-N(with)----------------------------+                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           +-MOD_ATT:N-ADJ+            |             +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+SUBJ:V+      |     |      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__SP__)
MOD_ATT:N-ADJ (mRNA,__NODE__)
MOD_ATT:N-N (cell,Hela)
SUBJ:V_PASS-N (treat,cell)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,mRNA)
COMP:V-N(in) (__SP__,cell)
COMP:V-N(with) (__SP__,agonist)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)

Analyse 376

                                         +----------------------------------------------------------------------------COMP:V-N(in)----------------------------------------------------------------------------+                     
                                         |                                +------------------------------------------------------------COMP:V-N(in)-----------------------------------------------------------+                     
                                         |                                |           +------------------------------------------------------COMP:V-N(of)-----------------------------------------------------+                     
                                         |                                |           +--------------OBJ:V-N-------------+                                                                                    |                     
                                         |       +-------MOD_ATT:N-N------+           |              +------SUBJ:V-N-----+                                                                                    |                     
                          +--MOD_ATT:N-N-+       |     +----MOD_ATT:N-N---+           |              +COMP:N-N(in)+      |      +--------OBJ:V-N--------+         +---MOD_ATT:N-N---+---------SUBJ:V-N--------+----OBJ:V-N----+     
                    +MOD_A+          +MOD+       |     |        +MOD_ATT:N+           |       +MOD_AT+       +MOD_+      +COMP:V-N(wit+      +MOD_A+MOD_+         |        +MOD_ATT:+              +-SUBJ:V-N-+       +MOD_ATT+     
                    |     |          |   |       |     |        |         |           |       |      |       |    |      |      |     |      |     |    |         |        |        |              |          |       |       |     
 Cycloheximide in cell culture and zVAD FMK in cell culture increase expression of __SP__ __NODE__ mRNA in Hela cells treated with agonist anti __SP__ Apo 1 [__NODE__] protein antibody and overproducing __SP__ __NODE__ protein .
MOD_ATT:N-N (culture,cell)
MOD_ATT:N-N (FMK,culture)
MOD_ATT:N-N (FMK,zVAD)
MOD_ATT:N-N (expression,cell)
MOD_ATT:N-N (expression,culture)
MOD_ATT:N-N (expression,increase)
MOD_ATT:N-ADJ (mRNA,__NODE__)
COMP:N-N(in) (mRNA,cell)
MOD_ATT:N-N (cell,Hela)
OBJ:V-N (treat,__SP__)
SUBJ:V-N (treat,mRNA)
COMP:V-N(with) (treat,agonist)
OBJ:V-N (with,Apo)
MOD_ATT:N-N (__SP__,anti)
MOD_ATT:N-N (Apo,__SP__)
MOD_ATT:N-N (antibody,[__NODE__])
MOD_ATT:N-N (antibody,protein)
COMP:V-N(in) (__SP__,FMK)
COMP:V-N(in) (__SP__,expression)
COMP:V-N(of) (__SP__,__SP__)
SUBJ:V-N (__SP__,antibody)
SUBJ:V-N (__SP__,overproduce)
OBJ:V-N (__SP__,protein)
MOD_ATT:N-ADJ (protein,__NODE__)